75. Cushing disease Clinical trials / Disease details

Clinical trials : 203 / Drugs : 191 - (DrugBank : 51) / Drug target genes : 62 - Drug target pathways : 128

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCT1021210011	10/06/2021	10/06/2021	A diagnosis of pseudo-Cushing's syndrome using dexamethason/CHR and Alprazolam	A diagnosis of pseudo-Cushing's syndrome using dexamethason/CRH and anxiolytic Alprazolam	Pseudo Cushing's Syndrome Glucocorticoid , Stress, dexamethasone suppression test;D003480	In patients suspected of having Cushing's syndrome or pseudo-Cushing's syndrome, we perform two loading tests, DEX/CRH and alprazolam tests, in order to confirm the differential ability of this test.	Asari Yuko	NULL	Recruiting	Not applicable	Not applicable	Both	100	Phase 2	Japan
2	NCT03974789 (ClinicalTrials.gov)	July 1, 2019	3/6/2019	Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms	Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms: Phase III Diagnostic Evaluation Study	Cushing Disease	Diagnostic Test: Blood test;Diagnostic Test: 24-hour Urine test;Diagnostic Test: Saliva swab;Diagnostic Test: Dexamethasone test	Centre Hospitalier Universitaire de Nimes	NULL	Recruiting	18 Years	N/A	All	380	Phase 3	France